Olema Pharmaceuticals Inc...

NASDAQ: OLMA · Real-Time Price · USD
5.52
0.26 (4.94%)
At close: Aug 15, 2025, 3:59 PM
5.54
0.36%
After-hours: Aug 15, 2025, 06:03 PM EDT

Olema Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-43.78M -30.39M -33.57M -34.55M -30.38M -30.97M -26.77M -21.5M -20.09M -28.29M -26.18M -22.72M -32.86M -23.03M -21.64M -17.71M -16.41M -15.34M
Depreciation & Amortization
132K 128K 116K 95K 94K 88K 88K 90K 99K 100K 97K 91K 85K 84K 73K 50K 31K 9K
Stock-Based Compensation
4.69M 4.38M 6.32M 5.63M 5.72M 4.91M 4.35M 4.11M 4.17M 4.63M 4.86M 4.28M 4.73M 4.96M 4.63M 4.16M 3.92M 3.21M
Other Working Capital
11.97M -11.97M -347K 5.2M 2.21M -414K 5.31M -5.16M -6.46M -307K 1.4M 331K 1.44M -496K -2.79M 1.53M 3.47M 1.3M
Other Non-Cash Items
-7.21M -1.81M -1.33M 5.28M -1.9M -2.07M 2.09M 320K 326K -542K -245K 137K 325K 329K 50.74M 82K 74K 64K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -4.04M -1.18M -1.09M n/a n/a n/a n/a n/a -49.46M n/a n/a n/a
Change in Working Capital
16.28M -16.28M 2.18M -3.46M -1.09M 4.54M 5.8M -4.58M -5.52M 3.71M 1.75M 225K 1.29M -251K -2.94M 1.33M 3.48M 974K
Operating Cash Flow
-29.88M -43.98M -26.28M -27.02M -27.55M -23.5M -18.48M -22.74M -22.12M -20.39M -19.71M -17.99M -26.46M -17.9M -18.6M -12.1M -8.9M -11.08M
Capital Expenditures
n/a n/a n/a 159K -6K -153K n/a n/a n/a n/a -173K -139K -21K -30K -699K -96K -360K -420K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -16.51K -20.3K n/a 30K 699K n/a n/a 459K
Purchase of Investments
-32.86M -142.85M -189.23M -47.48M -82.16M -76.09M -84.92M -95.95M -50.39M -24.37M -44.49M -18.45M -27.57M -123.15M -19.96M -132.14M -54.71M -280.16M
Sales Maturities Of Investments
67.1M 97.77M 74.81M 93.39M 77.29M 56.1M 54M 70.5M 64.5M 61.76M 61M 38.75M 57M 148.75M 26.66M 119.45M 66M 1M
Other Investing Acitivies
n/a n/a n/a -159K n/a -153K -30.91K 14K 14.11K 37.39K 16.51K 20.3K 29.43M -30K -699K -12.69M 11.29M -459K
Investing Cash Flow
34.23M -45.08M -114.42M 45.92M -4.88M -20.14M -30.91M -25.44M 14.11M 37.39M 16.34M 20.16M 29.41M 25.57M 6M -12.78M 10.93M -279.58M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
748K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-2.52M n/a 799K n/a 719K 920K 523K 869K 2.04M 220K 273K 106K 64K 33K 818K 57K 516K n/a
Financial Cash Flow
-2.52M 222K 244.3M 92K 15.61M 8.82M 523K 130.63M 2.04M 220K 273K 106K 64K 33K 818K 57K 516K n/a
Net Cash Flow
1.83M -88.84M 103.59M 19M -16.83M -34.82M -48.87M 82.45M -5.96M 17.22M -3.1M 2.28M 3.02M 7.7M -11.79M -24.82M 2.54M -290.67M
Free Cash Flow
-29.88M -43.98M -26.28M -26.86M -27.56M -23.65M -18.48M -22.74M -22.12M -20.39M -19.88M -18.13M -26.48M -17.93M -19.3M -12.19M -9.27M -11.5M